EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation

Haidong Zha, Xiao Liang, Long Xi, Jiamao Chen, Wenzhao Zhong, Zhen Yuan, Meng Xu, Ying Zheng iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Haidong Zha und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Hauptthemen laut MEDLINE: Nanoparticles, Ferritins, Apoferritins, Photothermal Therapy. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund of Macau SAR, Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combining the lysosomal targeting ability of human ferritin heavy chain (HFn) and the strong oxidizing property of gallic acid‐iron complex (GA‐Fe), a hybrid nanoparticle HFn/GA‐Fe was synthesized by a cross‐linking reaction. We discovered that HFn/GA‐Fe would specifically darken the color of tumors after intravenous injection without rendering notable toxicity in normal organs, as observed by visual inspection and photoacoustic imaging. HFn/GA‐Fe specifically bound to HFn receptor (TfR1/TIM‐2) and aggregated at the lysosomal pH. HFn/GA‐Fe induced endothelial cell death and tumor‐specific hemorrhage by generating reactive oxygen species (ROS). Under laser irradiation, the leaked deoxyhemoglobin significantly enhanced the photothermal effect and subsequently triggered anti‐tumor immune responses. The cavities of ferritin nanocages can further encapsulate drugs, endowing them with broader application prospects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesFerritinsApoferritinsPhotothermal TherapyNeoplasmsAnimalsHumansMiceCell Line, TumorReactive Oxygen SpeciesIronReceptors, Transferrin

Stichwörter der Autor:innen

fenton reactionhuman ferritin heavy chainphotothermal therapytransferrin receptor 1vascular disrupting agent

Substanzen

FerritinsApoferritinsReactive Oxygen SpeciesIronReceptors, Transferrin

Autor:innen und Institutionen

  • State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Faculty of Health Sciences, University of Macau, Macau, China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, University of Macau, Taipa, Macau, China.

ORCID-Profile: Ying Zheng

Förderung

  • Science and Technology Development Fund of Macau SAR
  • Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening

Zitieren

APA

Zha, H., Liang, X., Xi, L., Chen, J., Zhong, W., Yuan, Z., Xu, M., & Zheng, Y. (2026). Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505119

Vancouver

Zha H, Liang X, Xi L, Chen J, Zhong W, Yuan Z, et al. Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505119

BibTeX
@article{Zha2026,
  author = {Zha, Haidong and Liang, Xiao and Xi, Long and Chen, Jiamao and Zhong, Wenzhao and Yuan, Zhen and Xu, Meng and Zheng, Ying},
  title = {Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505119}
}
Kostenlos starten →